Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The ...

A team of researchers has developed a technique for diagnosing, managing and treating neurological disorders with minimal surgical risks.

Philadelphia-based Rothman Orthopaedic Institute has been at the forefront of spine care, and recently a team partnered with Thomas Jefferson University Hospita ...

According to Rice, ECI uses CSF, which surrounds the nervous system, as a pathway to deliver targeted devices. By performing ...

Utilizing the Dural Substitute Confetti technique during spinal cord stimulation trial implantation may reduce complications and shorten surgery time.

A team of researchers led by Rice University's Jacob Robinson and the University of Texas Medical Branch's Peter Kan has ...

A team of researchers led by Rice University's Jacob Robinson and the University of Texas Medical Branch's Peter Kan has developed a technique for ...

US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

HFX iQ is the first and only spinal cord stimulation (SCS) system integrating high-frequency SCS landmark evidence with cloud ...

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...